Naftifine hydrochloride

盐酸萘替芬

Report date: 2023/04/21 13:58:39
NME

Base Information

Drug NameNaftifine hydrochloride
Drug Alias Name萘甲胺盐酸盐Naftifinum hydrochlorideNaftifina hydrochloride盐酸奈桂胺盐酸奈替芬 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionErgosterol biosynthesis inhibitors
TargetsErgosterol
Therapy Area/IndicationsTinea CrurisTinea PedisTinea Capitis +[6] 
Global Approved IndicationsDermatomycosesMycoses
Approved Indications in ChinaDermatomycoses
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryBelizeUnited StatesPuerto Rico +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerz Pharma
China Registration ClassN/A

Develop Information

Active CompaniesLegacy Pharma IncFuzhou Jinshan Biological Pharmaceutical Co Ltd
Inactive CompaniesTaro Pharmaceuticals Usa IncMerz North America IncGenzum Life Sciences Llc
Active IndicationsDermatomycosesMycoses
Inactive IndicationsTinea CrurisTinea PedisTinea Capitis +[4] 

Other Information

ATC CodeD01AE22
Related LinksWikipediaDrugBankKEGG